APRIL mediates peritoneal B-1 cell homeostasis

Immunology Letters

Volumn 160, Issue 2, 2014, Pages 120-127

  Sindhava, Vishal J ^a   Scholz, Jean L ^a   Stohl, William ^b   Cancro, Michael P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

APRIL; B 1 cell; BLyS; HSPG; TACI

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; PROTEOHEPARAN SULFATE; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; BLYS RECEPTOR; MESSENGER RNA; PROTEIN BINDING; TNFRSF13B PROTEIN, MOUSE; TNFSF13 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL METABOLISM; CONTROLLED STUDY; MOUSE; NONHUMAN; PERITONEUM CELL; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN EXPRESSION; ANIMAL; CELL PROLIFERATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HOMEOSTASIS; HUMORAL IMMUNITY; IMMUNOLOGY; IMMUNOPHENOTYPING; KNOCKOUT MOUSE; METABOLISM; PERITONEUM; SIGNAL TRANSDUCTION;

ANIMALS; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTE SUBSETS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HEPARAN SULFATE PROTEOGLYCANS; HOMEOSTASIS; IMMUNITY, HUMORAL; IMMUNOPHENOTYPING; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; PERITONEUM; PROTEIN BINDING; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 84902550210     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.01.018     Document Type: Article

References (63)

1. Berland R., Wortis H.H. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 2002, 20:253-300.
2. Dorshkind K., Montecino-Rodriguez E. Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential. Nat Rev Immunol 2007, 7:213-219.
3. Alugupalli K.R., Gerstein R.M. Divide and conquer: division of labor by B-1 B cells. Immunity 2005, 23:1-2.
4. Kantor A.B., Merrill C.E., Herzenberg L.A., Hillson J.L. An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells. J Immunol 1997, 158:1175-1186.
5. Herzenberg L.A., Baumgarth N., Wilshire J.A. B-1 cell origins and VH repertoire determination. Curr Top Microbiol Immunol 2000, 252:3-13.
6. Haas K.M., Poe J.C., Steeber D.A., Tedder T.F. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 2005, 23:7-18.
7. Baumgarth N., Tung J.W., Herzenberg L.A. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin Immunopathol 2005, 26:347-362.
8. Alugupalli K.R., Leong J.M., Woodland R.T., Muramatsu M., Honjo T., Gerstein R.M. B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity 2004, 21:379-390.
9. Bos N.A., Bun J.C., Popma S.H., Cebra E.R., Deenen G.J., van der Cammen M.J., et al. Monoclonal immunoglobulin A derived from peritoneal B cells is encoded by both germ line and somatically mutated VH genes and is reactive with commensal bacteria. Infect Immun 1996, 64:616-623.
10. Victora G.D., Nussenzweig M.C. Germinal centers. Annu Rev Immunol 2012, 30:429-457.
11. Belnoue E., Pihlgren M., McGaha T.L., Tougne C., Rochat A.F., Bossen C., et al. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood 2008, 111:2755-2764.
12. Castigli E., Wilson S.A., Elkhal A., Ozcan E., Garibyan L., Geha R.S. Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation. J Allergy Clin Immunol 2007, 120:885-891.
13. Crowley J.E., Scholz J.L., Quinn W.J., Stadanlick J.E., Treml J.F., Treml L.S., et al. Homeostatic control of B lymphocyte subsets. Immunol Res 2008, 42:75-83.
14. Gross J.A., Dillon S.R., Mudri S., Johnston J., Littau A., Roque R., et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: impaired B cell maturation in mice lacking BLyS. Immunity 2001, 15:289-302.
15. Moore P.A., Belvedere O., Orr A., Pieri K., LaFleur D.W., Feng P., et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 1999, 285:260-263.
16. Schiemann B., Gommerman J.L., Vora K., Cachero T.G., Shulga-Morskaya S., Dobles M., et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 2001, 293:2111-2114.
17. Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 1999, 189:1747-1756.
18. Treml J.F., Hao Y., Stadanlick J.E., Cancro M.P. The BLyS family: toward a molecular understanding of B cell homeostasis. Cell Biochem Biophys 2009, 53:1-16.
19. Ng L.G., Ng C.H., Woehl B., Sutherland A.P., Huo J., Xu S., et al. BAFF costimulation of Toll-like receptor-activated B-1 cells. Eur J Immunol 2006, 36:1837-1846.
20. Shulga-Morskaya S., Dobles M., Walsh M.E., Ng L.G., MacKay F., Rao S.P., et al. B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J Immunol 2004, 173:2331-2341.
21. Lentz V.M., Cancro M.P., Nashold F.E., Hayes C.E. Bcmd governs recruitment of new B cells into the stable peripheral B cell pool in the A/WySnJ mouse. J Immunol 1996, 157:598-606.
22. Miller D.J., Hayes C.E. Phenotypic and genetic characterization of a unique B lymphocyte deficiency in strain A/WySnJ mice. Eur J Immunol 1991, 21:1123-1130.
23. Thompson J.S., Bixler S.A., Qian F., Vora K., Scott M.L., Cachero T.G., et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 2001, 293:2108-2111.
24. Yan M., Brady J.R., Chan B., Lee W.P., Hsu B., Harless S., et al. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr Biol 2001, 11:1547-1552.
25. Scholz J.L., Crowley J.E., Tomayko M.M., Steinel N., O'Neill P.J., Quinn W.J., et al. BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact. Proc Natl Acad Sci U S A 2008, 105:15517-15522.
26. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 1999, 190:1697-1710.
27. Gavin A.L., Duong B., Skog P., Ait-Azzouzene D., Greaves D.R., Scott M.L., et al. deltaBAFF, a splice isoform of BAFF, opposes full-length BAFF activity in vivo in transgenic mouse models. J Immunol 2005, 175:319-328.
28. Planelles L., Carvalho-Pinto C.E., Hardenberg G., Smaniotto S., Savino W., Gomez-Caro R., et al. APRIL promotes B-1 cell-associated neoplasm. Cancer Cell 2004, 6:399-408.
29. Guadagnoli M., Kimberley F.C., Phan U., Cameron K., Vink P.M., Rodermond H., et al. Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas. Blood 2011, 117:6856-6865.
30. Castigli E., Scott S., Dedeoglu F., Bryce P., Jabara H., Bhan A.K., et al. Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci U S A 2004, 101:3903-3908.
31. Varfolomeev E., Kischkel F., Martin F., Seshasayee D., Wang H., Lawrence D., et al. APRIL-deficient mice have normal immune system development. Mol Cell Biol 2004, 24:997-1006.
32. Schneider P., Takatsuka H., Wilson A., Mackay F., Tardivel A., Lens S., et al. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J Exp Med 2001, 194:1691-1697.
33. Shah H.B., Joshi S.K., Rampuria P., Devera T.S., Lang G.A., Stohl W., et al. BAFF- and APRIL-dependent maintenance of antibody titers after immunization with T-dependent antigen and CD1d-binding ligand. J Immunol 2013, 191:1154-1163.
34. von Bulow G.U., van Deursen J.M., Bram R.J. Regulation of the T-independent humoral response by TACI. Immunity 2001, 14:573-582.
35. Ray A., Dittel B.N. Isolation of mouse peritoneal cavity cells. J Vis Exp 2010, (35). 10.3791/1488.
36. Wu Y., Bressette D., Carrell J.A., Kaufman T., Feng P., Taylor K., et al. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS. J Biol Chem 2000, 275:35478-35485.
37. Jacob C.O., Guo S., Jacob N., Pawar R.D., Putterman C., Quinn W.J., et al. Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice. Arthritis Rheum 2012, 64:1610-1619.
38. Seshasayee D., Valdez P., Yan M., Dixit V.M., Tumas D., Grewal I.S. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 2003, 18:279-288.
39. Yan M., Wang H., Chan B., Roose-Girma M., Erickson S., Baker T., et al. Activation and accumulation of B cells in TACI-deficient mice. Nat Immunol 2001, 2:638-643.
40. Hendriks J., Planelles L., de Jong-Odding J., Hardenberg G., Pals S.T., Hahne M., et al. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ 2005, 12:637-648.
41. Ingold K., Zumsteg A., Tardivel A., Huard B., Steiner Q.G., Cachero T.G., et al. Identification of proteoglycans as the APRIL-specific binding partners. J Exp Med 2005, 201:1375-1383.
42. Sakurai D., Hase H., Kanno Y., Kojima H., Okumura K., Kobata T. TACI regulates IgA production by APRIL in collaboration with HSPG. Blood 2007, 109:2961-2967.
43. Reijmers R.M., Groen R.W., Kuil A., Weijer K., Kimberley F.C., Medema J.P., et al. Disruption of heparan sulfate proteoglycan conformation perturbs B-cell maturation and APRIL-mediated plasma cell survival. Blood 2011, 117:6162-6171.
44. Wallweber H.J., Compaan D.M., Starovasnik M.A., Hymowitz S.G. The crystal structure of a proliferation-inducing ligand, APRIL. J Mol Biol 2004, 343:283-290.
45. Stohl W., Metyas S., Tan S.M., Cheema G.S., Oamar B., Roschke V., et al. Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis 2004, 63:1096-1103.
46. Mohr E., Serre K., Manz R.A., Cunningham A.F., Khan M., Hardie D.L., et al. Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironments where plasmablasts mature. J Immunol 2009, 182:2113-2123.
47. Stein J.V., Lopez-Fraga M., Elustondo F.A., Carvalho-Pinto C.E., Rodriguez D., Gomez-Caro R., et al. APRIL modulates B and T cell immunity. J Clin Invest 2002, 109:1587-1598.
48. Montecino-Rodriguez E., Dorshkind K. B-1 B cell development in the fetus and adult. Immunity 2012, 36:13-21.
49. Sindhava V.J., Scholz J.L., Cancro M.P. Roles for BLyS family members in meeting the distinct homeostatic demands of innate and adaptive B cells. Front Immunol 2013, 4:37.
50. Marsters S.A., Yan M., Pitti R.M., Haas P.E., Dixit V.M., Ashkenazi A. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr Biol 2000, 10:785-788.
51. Kimberley F.C., van Bostelen L., Cameron K., Hardenberg G., Marquart J.A., Hahne M., et al. The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking. FASEB J 2009, 23:1584-1595.
52. Day E.S., Cachero T.G., Qian F., Sun Y., Wen D., Pelletier M., et al. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA. Biochemistry 2005, 44:1919-1931.
53. Reijmers R.M., Spaargaren M., Pals S.T. Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myeloma. FEBS J 2013, 280:2180-2193.
54. Buono M., Visigalli I., Bergamasco R., Biffi A., Cosma M.P. Sulfatase modifying factor 1-mediated fibroblast growth factor signaling primes hematopoietic multilineage development. J Exp Med 2010, 207:1647-1660.
55. Tung J.W., Mrazek M.D., Yang Y., Herzenberg L.A. Phenotypically distinct B cell development pathways map to the three B cell lineages in the mouse. Proc Natl Acad Sci U S A 2006, 103:6293-6298.
56. Sanderson R.D., Lalor P., Bernfield M. B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul 1989, 1:27-35.
57. Amezcua Vesely M.C., Schwartz M., Bermejo D.A., Montes C.L., Cautivo K.M., Kalergis A.M., et al. FcgammaRIIb and BAFF differentially regulate peritoneal B1 cell survival. J Immunol 2012, 188:4792-4800.
58. Sindhava V., Woodman M.E., Stevenson B., Bondada S. Interleukin-10 mediated autoregulation of murine B-1 B-cells and its role in Borrelia hermsii infection. PLoS ONE 2010, 5:e11445.
59. Craxton A., Magaletti D., Ryan E.J., Clark E.A. Macrophage- and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 2003, 101:4464-4471.
60. Pradet-Balade B., Medema J.P., Lopez-Fraga M., Lozano J.C., Kolfschoten G.M., Picard A., et al. An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein. EMBO J 2002, 21:5711-5720.
61. Huard B., McKee T., Bosshard C., Durual S., Matthes T., Myit S., et al. APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa. J Clin Invest 2008, 118:2887-2895.
62. Wolf A.I., Mozdzanowska K., Quinn W.J., Metzgar M., Williams K.L., Caton A.J., et al. Protective antiviral antibody responses in a mouse model of influenza virus infection require TACI. J Clin Invest 2011, 121:3954-3964.
63. O'Connor B.P., Raman V.S., Erickson L.D., Cook W.J., Weaver L.K., Ahonen C., et al. BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med 2004, 199:91-98.